The Mortgage Bankers Association (MBA) released its weekly report on mortgage applications Wednesday morning, noting a decrease of 0.5% in the group’s seasonally adjusted composite index for the week ending June 29. Mortgage loan rate movements were mixed last week.
Northrim BanCorp (NASDAQ: NRIM) and Hometrust Bancshares (NASDAQ:HTBI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.
March 23, 2018: Markets opened slightly higher Friday but the major indexes couldn’t hold onto their gains in the face of China’s first retaliatory shot in a trade war kicked off by Trump yesterday. China’s opening salvo did not hit soybeans or Boeing, two big and easy targets. The president signed the $1.3 trillion spending bill that will keep the government funded through September....More>>>
Source: ThinkstockDecember 4, 2017: The S&P 500 closed flat at 2,639.28. The DJIA closed up 0.2% at 24,289.84. Separately, the Nasdaq was down 1.1% at 6,775.37.
Monday was a somewhat mixed day for the broad U.S. markets. The Dow and S&P 500 both hit new highs over the course of the day, but each slid as the day went on. The Dow is still holding above a record 24,000. Crude oil pushed....More>>>
Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept....More>>>
Shares of risk management company RPX Corp. (NASDAQ:RPXC) popped as much as 15% in trading Wednesday after buyout rumors started to swirl in the market. At 2:55 p.m. EST, shares had settled down to an 11.2% gain on the day.
Rumors from IAM Media have circulated that a private equity firm is interested in buying RPX, and Baird analyst Jeffrey Meuler gave....More>>>
Treasury yields slightly declined Monday, backing further away from the closely watched 3% level as investors looked ahead to the new Federal Reserve bosss first congressional testimony in hopes for clues on the pace of rate hikes.
Let’s get right to it, Village Farms International (OTCQX:VFFIF or TSE:VFF) has the potential to be the low cost producer in the Canadian medical marijuana industry. This investment is based on stages of development, which I plan to explore with readers and let you know, in likely the most transparent way possible, how I plan to “play” this player in this promising industry.
SOFIA, Bulgaria The European Union has called on U.S. President Donald Trump's administration to stop threating it with tariffs on steel and aluminum, saying Thursday it is prepared to discuss trade but not at gun-point.
In March, Trump slapped tariffs of 25% on steel imports and 10% on impo
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...
Editor's note: Seeking Alpha is proud to welcome Michael McGrath as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more 禄
If you're not familiar with how Social Security works, you might assume that there's a single age at which eligible recipients have to file for benefits. Not so. You actually get an eight-year window to claim benefits that begins at age 62 and carries through until age 70. (Technically, you're no
The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.